Shares of biotech Summit Therapeutics ( SMMT 9.31%) skyrocketed 583.7% in 2024, according to data from S&P Global Market ...

On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...

Monoclonal Antibody to Inhibit IL33 for Autoimmune Disorders is under clinical development by Eli Lilly and Co and currently in Phase I for Autoimmune Disorders.

According to Inan’s team: “There is no documented production process of atezolizumab biosimilar in the literature except one ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

The discovery, led by researchers at Penn State, could eliminate the need for refrigeration for hundreds of life-saving ...

Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

AstraZeneca Pharma India rose 1.10% to Rs 10,754 after the firm received approval from the Central Drugs Standard Control Organisation (CDSCO) to import pharmaceutical formulations of eculizumab ...

Eculizumab, a monoclonal antibody, is indicated for the treatment of two rare and life-threatening conditions: Paroxysmal ...

Tiziana Life Sciences (TLSA) announced findings on the prolonged benefits of its nasal anti-CD3 monoclonal antibody in sustaining tissue ...